These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15981717)

  • 21. Somatostatin receptor scintigraphy versus chromogranin A assay in the management of patients with neuroendocrine tumors of different types: clinical role.
    Cimitan M; Buonadonna A; Cannizzaro R; Canzonieri V; Borsatti E; Ruffo R; De Apollonia L
    Ann Oncol; 2003 Jul; 14(7):1135-41. PubMed ID: 12853358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Imaging of neuroendocrine tumors].
    Gualdi GF; Casciani E; Polettini E
    Clin Ter; 2001; 152(2):107-21. PubMed ID: 11441522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Significance of false-positive findings of somatostatin receptor scintigraphy in diagnosis of neuroendocrine tumors of the gastroenteropancreatic system].
    Faiss S; Scherübl H; Bäder M; Fett U; Koppenhagen K; Wiedenmann B; Riecken EO
    Z Gastroenterol; 1994 May; 32(5):243-6. PubMed ID: 7915450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Imaging methods in diagnosis of neuroendocrine tumors of the gastrointestinal tract].
    Zimmer T; Faiss S; Buhr HJ; Hamm B; Wiedenmann B
    Bildgebung; 1995 Mar; 62(1):5-13. PubMed ID: 7756824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative analysis of diagnostic techniques for localization of gastrointestinal neuroendocrine tumors.
    Gibril F; Jensen RT
    Yale J Biol Med; 1997; 70(5-6):509-22. PubMed ID: 9825478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SPECT/CT hybrid imaging with 111In-pentetreotide in assessment of neuroendocrine tumours.
    Krausz Y; Keidar Z; Kogan I; Even-Sapir E; Bar-Shalom R; Engel A; Rubinstein R; Sachs J; Bocher M; Agranovicz S; Chisin R; Israel O
    Clin Endocrinol (Oxf); 2003 Nov; 59(5):565-73. PubMed ID: 14616879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of somatostatin receptor scintigraphy during preoperative staging of non-functioning pancreatic neuroendocrine tumours.
    Jilesen AP; Hoefnagel SJ; Busch OR; Bennink RJ; Gouma DJ; Nieveen van Dijkum EJ
    Clin Radiol; 2016 Jun; 71(6):537-42. PubMed ID: 27016111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Intraoperative isotope-controlled probe localization after somatostatin receptor scintigraphy of occult neuroendocrine tumors].
    Runkel N; Bäder M; Wiedenmann B; Buhr HJ
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1034-7. PubMed ID: 9931782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical value of somatostatin receptor scintigraphy. Studies of pre- and intraoperative localization of gastrointestinal and pancreatic tumors].
    Adams S; Baum RP; Adams M; Wenisch HJ; Schumm-Draeger PM; Encke A; Usadel KH; Hör G
    Med Klin (Munich); 1997 Mar; 92(3):138-43. PubMed ID: 9173204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results and potential of somatostatin receptor imaging in gastroenteropancreatic tract tumours.
    Chiti A; Briganti V; Fanti S; Monetti N; Masi R; Bombardieri E
    Q J Nucl Med; 2000 Mar; 44(1):42-9. PubMed ID: 10932600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Value of Somatostatin Receptor Scintigraphy (SRS) in Patients with NETG1/G2 Pancreatic Neuroendocrine Neoplasms (p-NENs).
    Kolasińska-Ćwikła AD; Konsek SJ; Buscombe JR; Maciejkiewicz K; Cichocki A; Roszkowska-Purska K; Sawicki Ł; Tenderenda M; Cwikla JB
    Nucl Med Rev Cent East Eur; 2019; 22(1):1-7. PubMed ID: 30276787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and imaging follow-up after exhaustive liver resection of endocrine metastases: a 15-year monocentric experience.
    Scigliano S; Lebtahi R; Maire F; Stievenart JL; Kianmanesh R; Sauvanet A; Vullierme MP; Couvelard A; Belghiti J; Ruszniewski P; Le Guludec D
    Endocr Relat Cancer; 2009 Sep; 16(3):977-90. PubMed ID: 19470616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localisation of neuroendocrine tumours of the upper gastrointestinal tract.
    Zimmer T; Ziegler K; Bäder M; Fett U; Hamm B; Riecken EO; Wiedenmann B
    Gut; 1994 Apr; 35(4):471-5. PubMed ID: 8174983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endoscopic ultrasonography and somatostatin receptor scintigraphy in the preoperative localisation of insulinomas and gastrinomas.
    Zimmer T; Stölzel U; Bäder M; Koppenhagen K; Hamm B; Buhr H; Riecken EO; Wiedenmann B
    Gut; 1996 Oct; 39(4):562-8. PubMed ID: 8944566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of (111)In-DTPA-pentetreotide scintigraphy in accurate diagnosis of neuroendocrine gastroenteropancreatic tumors.
    Ichijo T; Ishikawa M; Shimojo M; Tsubuku M; Tsuboi K; Miyachi Y
    J Hepatobiliary Pancreat Surg; 2001; 8(5):473-8. PubMed ID: 11702259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 111In-pentetreotide scintigraphy in the detection of insulinomas: importance of SPECT imaging.
    Schillaci O; Massa R; Scopinaro F
    J Nucl Med; 2000 Mar; 41(3):459-62. PubMed ID: 10716319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined visual and quantitative assessment of somatostatin receptor scintigraphy for staging and restaging of neuroendocrine tumors.
    Ueki Y; Otsuka H; Otani T; Kasai R; Otomi Y; Ikemitsu D; Azane S; Kunikane Y; Bando T; Matsuda N; Okada Y; Takayama T; Harada M
    Jpn J Radiol; 2024 May; 42(5):519-535. PubMed ID: 38345724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic uses of radiolabelled somatostatin receptor analogues in gastroenteropancreatic endocrine tumours.
    Gibril F; Jensen RT
    Dig Liver Dis; 2004 Feb; 36 Suppl 1():S106-20. PubMed ID: 15077919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of chromogranin A levels and somatostatin receptor scintigraphy findings in the evaluation of metastases in carcinoid tumors.
    Namwongprom S; Wong FC; Tateishi U; Kim EE; Boonyaprapa S
    Ann Nucl Med; 2008 May; 22(4):237-43. PubMed ID: 18535873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous 68Ga-DOTATOC PET/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial results.
    Beiderwellen KJ; Poeppel TD; Hartung-Knemeyer V; Buchbender C; Kuehl H; Bockisch A; Lauenstein TC
    Invest Radiol; 2013 May; 48(5):273-9. PubMed ID: 23493121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.